...Algeta exercised its option under an extended 2010 deal for an exclusive worldwide license to Lumiphore's...
...in the lanthanide and actinide groups to tumor-targeting molecules. Algeta also received a license from Lumiphore...
...of chelators, with the option of including a further selection of compounds within the license. Lumiphore...

...Algeta received an exclusive option for exclusive rights to use Lumiphore's Lumi4 isophthalamide chelation technology to...
...based on chelators that bind metals in the lanthanide and actinide groups to tumor-targeting molecules. Lumiphore...
...expire in one year. Further financial terms were not disclosed. Algeta ASA (OSE:ALGETA), Oslo, Norway Lumiphore Inc....

...Brahms received exclusive rights outside the U.S. to incorporate Lumiphore's Lumi4 fluorescent lanthanide detection reagents technology...
...including tests for Down syndrome. Financial terms were not disclosed. Brahms AG , Hennigsdorf, Germany Lumiphore Inc....

...Cisbio received an exclusive, worldwide license to incorporate Lumiphore's Lumi4 fluorescent lanthanide detection reagents into Cisbio's...
...molecular interactions of proteins in vivo. Financial terms were not disclosed. Cisbio , Saclay, France Lumiphore Inc....

...license from the university to two patents covering fluorescence detection technology using luminescent lanthanide complexes. Lumiphore Inc....